Clinical trials with a-Galactosylceramide (KRN7000) in advanced cancer

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Original languageUndefined/Unknown
Title of host publicationNatural killer T cells: Balancing the regulation of tumor immunity, Cancer drug discovery and development
PublisherSpringer Science + Business Media
Pages1
Publication statusPublished - 2011

Cite this

Schneiders, F. L., Scheper, R. J., Bontkes, H. J., von Blomberg, B. M. E., van den Eertwegh, A. J. M., de Gruijl, T. D., & van der Vliet, J. J. (2011). Clinical trials with a-Galactosylceramide (KRN7000) in advanced cancer. In Natural killer T cells: Balancing the regulation of tumor immunity, Cancer drug discovery and development (pp. 1). Springer Science + Business Media.
Schneiders, F.L. ; Scheper, R.J. ; Bontkes, H.J. ; von Blomberg, B.M.E. ; van den Eertwegh, A.J.M. ; de Gruijl, T.D. ; van der Vliet, J.J. / Clinical trials with a-Galactosylceramide (KRN7000) in advanced cancer. Natural killer T cells: Balancing the regulation of tumor immunity, Cancer drug discovery and development. Springer Science + Business Media, 2011. pp. 1
@inbook{8f212d6a6f634b56ba1c2c5bf4377448,
title = "Clinical trials with a-Galactosylceramide (KRN7000) in advanced cancer",
author = "F.L. Schneiders and R.J. Scheper and H.J. Bontkes and {von Blomberg}, B.M.E. and {van den Eertwegh}, A.J.M. and {de Gruijl}, T.D. and {van der Vliet}, J.J.",
year = "2011",
language = "Undefined/Unknown",
pages = "1",
booktitle = "Natural killer T cells: Balancing the regulation of tumor immunity, Cancer drug discovery and development",
publisher = "Springer Science + Business Media",

}

Schneiders, FL, Scheper, RJ, Bontkes, HJ, von Blomberg, BME, van den Eertwegh, AJM, de Gruijl, TD & van der Vliet, JJ 2011, Clinical trials with a-Galactosylceramide (KRN7000) in advanced cancer. in Natural killer T cells: Balancing the regulation of tumor immunity, Cancer drug discovery and development. Springer Science + Business Media, pp. 1.

Clinical trials with a-Galactosylceramide (KRN7000) in advanced cancer. / Schneiders, F.L.; Scheper, R.J.; Bontkes, H.J.; von Blomberg, B.M.E.; van den Eertwegh, A.J.M.; de Gruijl, T.D.; van der Vliet, J.J.

Natural killer T cells: Balancing the regulation of tumor immunity, Cancer drug discovery and development. Springer Science + Business Media, 2011. p. 1.

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

TY - CHAP

T1 - Clinical trials with a-Galactosylceramide (KRN7000) in advanced cancer

AU - Schneiders, F.L.

AU - Scheper, R.J.

AU - Bontkes, H.J.

AU - von Blomberg, B.M.E.

AU - van den Eertwegh, A.J.M.

AU - de Gruijl, T.D.

AU - van der Vliet, J.J.

PY - 2011

Y1 - 2011

M3 - Chapter

SP - 1

BT - Natural killer T cells: Balancing the regulation of tumor immunity, Cancer drug discovery and development

PB - Springer Science + Business Media

ER -

Schneiders FL, Scheper RJ, Bontkes HJ, von Blomberg BME, van den Eertwegh AJM, de Gruijl TD et al. Clinical trials with a-Galactosylceramide (KRN7000) in advanced cancer. In Natural killer T cells: Balancing the regulation of tumor immunity, Cancer drug discovery and development. Springer Science + Business Media. 2011. p. 1